Comparison of predose vs 2-h postdose blood metabolites/cyclosporine ratios in kidney and liver transplant patients

被引:12
作者
Fernández-Marmiesse, A [1 ]
Hermida, J [1 ]
Tutor, JC [1 ]
机构
[1] Univ Santiago, Hosp Clin, Cent Lab, Santiago De Compostela, Spain
关键词
cyclosporine; time of blood sampling; metabolites/cyclosporine ratio; immunoassays specificity;
D O I
10.1016/S0009-9120(00)00147-8
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: It has recently been suggested that when adjusting doses of cyclosporine (CsA), determining its concentration in blood samples taken 2 h postdose (C-2) is more clinically beneficial than using the predose concentration (C-0). We determined C-0 and C-2 concentrations of CsA and their metabolites in samples taken from nine kidney and seven liver transplant patients. Similarly, the so-called metabolic ratios (MR)-metabolites to CsA parent ratios-were calculated to characterise the most suitable moment of blood sampling for obtaining a greater analytical specificity with monoclonal immunoassays. Methods: The determination of CsA and CsA + metabolites was made using the enzyme multiplied immunotechnique and the polyclonal fluorescence polarization immunoassay Abbott TDx, respectively. Results: The poor correlation between C-0 and C-2 of CsA (n = 82, r = 0.387, p < 0.001) is greatly inferior to that obtained between C-0 and C-2 of metabolites (n = 82, r = 0.912, p < 0.001). A highly significant difference (p < 0.001) was found between MR0 values (mean 2.87 +/- 0.12, median 2.48) and MR2 values (mean 1.73 +/- 0.09, median 1.46), although there is a good correlation between them (r = 0.878, p ( 0.001). Conclusions: The extent of the positive bias (deviation) of CsA immunoassays compared with the high-performance liquid chromatography results is related to the MR values. As the MR2 values are significantly lower than the corresponding MR0, in practice a greater analytical specificity would be obtained with the different monoclonal immunoassays in the determination of the 2 h postdose CsA concentration than in that of trough concentration. Copyright (C) 2000 The Canadian Society of Clinical Chemists.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 14 条
[1]  
[Anonymous], 2010, CLIN PHARMACOKINET
[2]   Comparison of neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients [J].
Cantarovich, M ;
Barkun, JS ;
Tchervenkov, JI ;
Besner, JG ;
Aspeslet, L ;
Metrakos, P .
TRANSPLANTATION, 1998, 66 (12) :1621-1627
[3]  
Cantarovich M, 1998, CLIN TRANSPLANT, V12, P243
[4]   PARALLEL BLOOD-CONCENTRATIONS OF 2ND-GENERATION CYCLOSPORINE METABOLITES AND BILIRUBIN IN LIVER GRAFT RECIPIENTS [J].
CHRISTIANS, U ;
KOHLHAW, K ;
SURIG, T ;
BADER, A ;
SCHOTTMANN, R ;
LINCK, A ;
RINGE, B ;
SEWING, KF .
THERAPEUTIC DRUG MONITORING, 1995, 17 (05) :487-498
[5]   Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection -: Results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8) [J].
Grant, D ;
Kneteman, N ;
Tchervenkov, J ;
Roy, A ;
Murphy, G ;
Tan, A ;
Hendricks, L ;
Guilbault, N ;
Levy, G .
TRANSPLANTATION, 1999, 67 (08) :1133-1137
[6]   METHODOLOGICAL AND CLINICAL ASPECTS OF CYCLOSPORINE MONITORING - REPORT OF THE ASSOCIATION OF CLINICAL BIOCHEMISTS TASK-FORCE [J].
HOLT, DW ;
JOHNSTON, A ;
ROBERTS, NB ;
TREDGER, JM ;
TRULL, AK .
ANNALS OF CLINICAL BIOCHEMISTRY, 1994, 31 :420-446
[7]   A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients [J].
Keown, P ;
Landsberg, D ;
Halloran, P ;
Shoker, A ;
Rush, D ;
Jeffery, J ;
Russell, D ;
Stiller, C ;
Muirhead, N ;
Cole, E ;
Paul, L ;
Zaltzman, J ;
Loertscher, R ;
Daloze, P ;
Dandavino, R ;
Boucher, A ;
Handa, P ;
Lawen, J ;
Belitsky, P ;
Parfrey, P .
TRANSPLANTATION, 1996, 62 (12) :1744-1752
[8]   Neoral monitoring by simplified sparse sampling area under the concentration-time curve - Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation [J].
Mahalati, K ;
Belitsky, P ;
Sketris, I ;
West, K ;
Panek, R .
TRANSPLANTATION, 1999, 68 (01) :55-62
[9]   Therapeutic drug monitoring of cyclosporine and tacrolimus [J].
Oellerich, M ;
Armstrong, VW ;
Schütz, E ;
Shaw, LM .
CLINICAL BIOCHEMISTRY, 1998, 31 (05) :309-316
[10]   LAKE-LOUISE-CONSENSUS-CONFERENCE ON CYCLOSPORINE ONITORING IN ORGAN-TRANSPLANTATION - REPORT OF THE CONSENSUS PANEL [J].
OELLERICH, M ;
ARMSTRONG, VW ;
KAHAN, B ;
SHAW, L ;
HOLT, DW ;
YATSCOFF, R ;
LINDHOLM, A ;
HALLORAN, P ;
GALLICANO, K ;
WONIGEIT, K ;
SCHUTZ, E ;
SCHRAN, H ;
ANNESLEY, T .
THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :642-654